Trojan Bio
2 known investors
Find your way into Trojan Bio
Trojan Bio develops bispecific antibodies for cancer immunotherapy, using an AI-driven platform that pairs a cancer-targeting module with a viral immunity activation module to mark tumor cells as virally infected and recruit anti-viral immune responses. Its approach is designed to be switchable across different tumor types.
Investors · 2
Frequently asked questions
- What does Trojan Bio do?
- Trojan Bio develops bispecific antibodies for cancer immunotherapy, using an AI-driven platform that pairs a cancer-targeting module with a viral immunity activation module to mark tumor cells as virally infected and recruit anti-viral immune responses. Its approach is designed to be switchable across different tumor types.
- Who are Trojan Bio's investors?
- Trojan Bio's investors include NFX, Peregrine Ventures.